Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2006-05-30
2006-05-30
Housel, James (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S235100, C424S149100, C424S189100, C530S328000, C530S388300, C536S023100
Reexamination Certificate
active
07052830
ABSTRACT:
Novel hepatitis C virus (HCV) polypetides are provided which are not encoded by the standard HCV open reading frame. These alternate reading frame polypeptides are useful, inter alia, in vaccine compositions, in diagnosing HCV infection, and as therapeutic targets.
REFERENCES:
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5443965 (1995-08-01), Reyes et al.
patent: 5728520 (1998-03-01), Weiner et al.
patent: 5840839 (1998-11-01), Wang et al.
patent: 6027729 (2000-02-01), Houghton et al.
patent: 6054264 (2000-04-01), Chien et al.
patent: 6074846 (2000-06-01), Ralston et al.
patent: 6150087 (2000-11-01), Chien
patent: 6171782 (2001-01-01), Houghton et al.
patent: WO 94/25601 (1994-11-01), None
patent: WO 94/25601 (1994-11-01), None
patent: WO 96/05315 (1996-02-01), None
patent: WO 96/05315 (1996-02-01), None
patent: WO 96/40227 (1996-12-01), None
Rodriguez-Lopez, M. “Immunogenecity of variable regions of hepatitis C virus proteins” Journ. of Gen. Virol. (1999) 80, 727-73.
Varaklioti et al., Alternate Translation Occurs within the Core Coding Region of the Hepatitis C Viral Genome. The Journal of Biological Chemistry 20:17713-17721, 2002.
Boulant, S., et al. “Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from Genotype 1b.”J Biol Chem.Nov. 14, 2003; 278(46):45785-92.
Branch, A.D., et al. “The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others.”Semin Liver Dis.Feb. 2005; 25(1):105-17.
Choi, J., et al. “Triple decoding of hepatitis C virus RNA by programmed translational frameshifting.”Mol Cell Biol.Mar. 2003; 23(5):1489-97.
Komurian-Pradel, F., et al. “Antigenic relevance of F protein in chronic hepatitis C virus infection.”Hepatology.Oct. 2004; 40(4):900-9.
Ogata, S., et al. “Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.”J Clin Microbiol.Oct. 2002; 40(10):3625-30.
Roussel, J., et al. “Characterization of the expression of the Hepatitis C virus F protein.”J Virol.2003; 84:1751-1759.
Tan, S-L., et al. “Hepatitis C therapeutics: current status and emerging strategies.”Nature.Nov. 2002; 1:867-881.
Vassilaki, N. et al. “Two alternative translation mechanisms are responsible for the expression of the HCV ARFT/F/Core +1 coding open reading frame.”J Biol Chem.Oct. 2003; 278: 40503-40513.
Walewski, J.L., et al. “Reading between the lines: evidence for a new Hepatitis C virus protein.”Hepatology.Sep. 2003; 36(3):757-60.
Walewski, J.L., et al. “Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions.”RNA.May 2002; 8(5):557-71.
Walewski, J.L., et al. “Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame.”RNA.May 2001; 7(5):710-21.
Walewski, J.L., et al. “HCV patients have antibodies against a novel protein encoded in a second reading frame.”Hepatology.Oct. 1998; 278A#462.
Xu, Z., et al. “Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic reticulum.”J Virol.Jan. 2003; 77(2):1578-83.
Yeh, C-T, et al. “Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to the synthesis of a short core protein product.”J Gastroenterol Hepatol.Feb. 2000; 15(2):182-91.
Feucht, H.-H. et al. “Study on Reliability of Commercially Available Hepatitis C Virus Antibody Tests”Journal of Clinical Microbiology33(3):620-624 (Mar. 1995).
Walewski, Jose L. et al. “HCV Patients Have Antibodies Against a Novel Protein Encoded in a Second Reading Frame”Hepatology28(4, Pt. 2):278A, Abstr. 462 (Oct. 1998).
Lo, S.-Y. et al. (Feb. 15, 1994) Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution,Virology199(1):124-31.
Lo, S.-Y. et al. (Nov. 10, 1995) Differential subcellular localization of hepatitis C virus core gene productsVirology213(2):455-61.
Lo, S.-Y. et al. (Aug. 1996) Interaction between hepatitis C virus core protein and E1 envelope proteinJ. Virol.70(8):5177-82.
Malarkannan, S. et al. (Jun. 1999) Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanismImmunity10(6):681-90.
Ray, B.R et al. (Jul. 1996) Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotypeJ. Virol.70(7):4438-43.
Wang, J. et al. (Sep. 1991) Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartmentJ. Virol.65:5080-83.
Walewski et al. (1999) A western blot assay for detection of patient antibodies to an HCV alternate reading frame proteinAbstract in Hepatology30(4):41A poster 163.
Xu, Z. et al. (2001) Synthesis of a novel hepatitis C virus protein by ribosomal frameshiftEMBO J.20(14):3840-48.
Bullock T.N.J. et al. “Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames,”J. Exp. Med.,184:1319-29 (1996).
Ina, Y. et al., “Reduction of synonymous substitutions in the core protein gene of hepatitis C virus,”J. Mol. Evol.,38:50-56 (1994).
Smith, D. B. et al., “Characteristics of nucleotide substitution in the hepatitis C virus genome: Constraints on sequence change in coding regions at both ends of the genome,”J. Mol. Evol.,45:238-246 (1997).
Valenzuela, P. et al., “The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes,” inAnimal Virus Genetics, Acedemic Press, p 57-70 (1980).
Branch Andrea D.
Stump Decherd D.
Walewski Jose L.
Brown Timothy M.
DeConti, Jr. Giulio A.
Housel James
Lahive & Cockfield, LLP.
Williams Megan E.
LandOfFree
Hepatitis C virus peptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus peptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus peptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3578861